ArticleTropical medicine and infectious disease2025
Retrospective Cohort Study Comparing Outcomes and High-Risk Factors of Patients Presenting with Necrotizing Soft Tissue Infections in Far North Queensland-20 Years of Experience.
Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNecrotizing soft tissue infections (NSTIs) are high-morbidity and high-mortality conditions that particularly affect comorbid patients. Previous Australian cohorts had limited numbers of patients within them; however, due to geographical, social and climate factors, North Queensland has significantly higher presentations than most of the country.
methodsWe have completed a retrospective cohort study between 2002 and 2012 and 2014 and 2024 of patients with ICD codes and documented clinical histories consistent with NSTI who presented to a single tertiary centre.
results213 patients were identified. There was a 14% mortality rate, and common comorbidities were diabetes, smoking, high BMI and high ethanol use. Patients were likely to present with vital signs within the normal range and high inflammatory markers. Of the patients, 51% identified as First Nations, an incidence rate 88 times higher than all other ethnicities put together. First Nations patients were younger (51.78 vs. 55.74 years,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.